In vivo viability studies of two additive solutions in the postthaw preservation of red cells held for 3 weeks at 4°C
Authors:
- 1 September 1993
- journal article
- clinical trial
- Published by Wiley in Transfusion
- Vol. 33 (9) , 709-712
Abstract
An optimized additive solution was developed for the postthaw preservation of red cells that contained adenine, glucose, disodium phosphate, and citrate buffer. This solution, called AS‐17, was compared to AS‐3 solution in a clinical trial using 40 subjects (20 in each arm). Fresh‐frozen red cells were thawed and deglycerolized after 1 to 18 months and subjected to a second period of storage in either solution for up to 3 weeks at refrigerator temperatures. Both solutions yielded red cells with 24‐hour survivals in excess of 75 percent. Cells stored in AS‐3 for 21 days had a mean survival of 77 +/− 8 percent and cells stored in AS‐17 a mean survival of 79 +/− 11 percent. The AS‐17 solution resulted in improved maintenance of pH, p50, and 2,3 DPG compared to that with AS‐3, but both solutions appear adequate for 3 weeks of postthaw storage.Keywords
This publication has 7 references indexed in Scilit:
- The extension of 4 degrees C storage time of frozen‐thawed red cellsTransfusion, 1992
- Ascorbate-2-phosphate in red cell preservation. Clinical trials and active componentsTransfusion, 1988
- Liquid storage at 4 ° C of previously frozen red cellsTransfusion, 1987
- Post-Thaw Storage at 4°C of Previously Frozen Red Cells with Retention of 2,3-DPGVox Sanguinis, 1987
- Development of an optimized additive solution containing ascorbate‐2‐ phosphate for the preservation of red cells with retention of 2,3 diphosphoglycerateTransfusion, 1985
- Studies on the Mechanism of Human Red Cell Loss of Viability during Storage at +4°C in vitro.Vox Sanguinis, 1985
- Proposed standardization of methods for determining the 24‐hour survival of stored red cellsTransfusion, 1984